R. Wei

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

Mitchell R. Smith, Robert E. Coleman, Laurence Klotz et al. · Annals of Oncology · 2014 · 145 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational study

Guy Hechmati, S. Cure, A. Gouépo et al. · Journal of Medical Economics · 2013 · 60 citations · Full text

Medicine, Oncology, Surgery +17

Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective – prospective observational study – a cohort from 4 European countries

H. Hoefeler, Ignacio Durán, Guy Hechmati et al. · Journal of bone oncology · 2014 · 50 citations · Full text

Medicine, Oncology, Surgery +17

Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases

R. Wei, T Y Li, Xincai Yang et al. · Genetics and Molecular Research · 2016 · 33 citations · Full text

Medicine, Oncology, Urology +17

UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111)

Constantine S. Tam, M. Wang, David Simpson et al. · Hematological Oncology · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17